Acute AST and ALT Elevation: Acute Liver Failure

A summary table:

Introduction

Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) are essential liver enzymes that reflect hepatocyte integrity and liver function. Elevation of these enzymes is a common finding in clinical practice and can be caused by a variety of conditions ranging from benign self-limiting illnesses to life-threatening liver injury. For internal medicine residents, understanding the nuances of AST and ALT elevation is critical in developing differential diagnoses, directing further investigations, and initiating appropriate management. This article delves into the key causes of AST and ALT elevations, focusing on three major categories: hepatitis infection flares, ischemia (shock liver), and toxin-induced hepatitis.

The Basics: AST and ALT Physiology

• AST (Aspartate Aminotransferase): Primarily found in the liver, heart, muscles, kidneys, brain, and red blood cells, AST is released into the bloodstream when these tissues are damaged. It is not specific to liver injury alone.
• ALT (Alanine Aminotransferase): More specific to the liver, ALT is found in hepatocytes and is released predominantly during hepatocellular injury.

The normal AST/ALT ratio is close to 1:1, but patterns of enzyme elevation, particularly the AST/ALT ratio, can provide valuable clues regarding the underlying cause of liver injury.

Major Causes of AST/ALT Elevation

1. Hepatitis Infection Flare (Viral and Autoimmune)

Hepatitis is a major cause of elevated liver enzymes, with viral and autoimmune forms being particularly important for residents to recognize.

Viral Hepatitis

Acute viral hepatitis (e.g., Hepatitis A, B, C, D, E) often presents with marked elevation of ALT, typically higher than AST, as ALT is more liver-specific. Chronic viral hepatitis, particularly hepatitis B and C, can cause intermittent flares of elevated liver enzymes, reflecting periods of viral reactivation and hepatocellular injury.

Clinical Features:

• Acute Phase: Jaundice, fatigue, malaise, anorexia, nausea, and right upper quadrant pain.
• Chronic Phase: Symptoms may be subtle, with occasional mild jaundice or fatigue. Chronic liver disease features, such as ascites, splenomegaly, or encephalopathy, may develop in advanced cases.

Diagnosis:

• Serology: Hepatitis markers (HBsAg, anti-HCV, anti-HAV IgM) are key.
• AST/ALT Pattern: ALT is typically higher than AST, especially in acute hepatitis.
• Autoimmune Hepatitis: Elevated immunoglobulins (IgG), positive autoantibodies (ANA, SMA), and liver biopsy findings are crucial for diagnosis.

Management:

• Acute Hepatitis: Supportive care is the mainstay for hepatitis A and E, while antiviral therapy is indicated for hepatitis B and C, especially in chronic cases.
• Autoimmune Hepatitis: Immunosuppressive therapy, such as corticosteroids and azathioprine, is used to control inflammation.

Key Considerations for Residents:

• Always assess for viral serologies when evaluating a patient with elevated liver enzymes.
• Monitor chronic hepatitis patients for potential flares, which may require antiviral therapy or immunosuppressants.

2. Ischemic Hepatitis (Shock Liver)

Ischemic hepatitis, or "shock liver," results from diminished blood flow to the liver, typically due to hypotension, heart failure, or circulatory shock.

Pathophysiology:

Hepatocytes are highly sensitive to oxygen deprivation. Ischemia leads to massive hepatocellular death, and this damage is reflected by markedly elevated AST and ALT levels, often exceeding 1000 IU/L. AST tends to rise more than ALT, likely due to its wider distribution in other tissues such as cardiac and skeletal muscle.

Clinical Features:

Patients with ischemic hepatitis typically present with symptoms related to the underlying cause of ischemia:

• Cardiovascular collapse: Hypotension, tachycardia, and signs of shock (e.g., cool extremities, altered mental status).
• Heart failure: Dyspnea, peripheral edema, jugular venous distention.

Diagnosis:

• Lab Findings: AST and ALT levels may rise dramatically (>1000 IU/L), with AST typically higher than ALT. Bilirubin and alkaline phosphatase may remain relatively normal in the early stages.
• Supporting Evidence: Echocardiography, EKG, and central venous pressure monitoring can help confirm the ischemic cause.

Management:

• Hemodynamic Stabilization: Correcting the underlying circulatory failure is paramount (e.g., fluids, inotropes, or vasopressors in shock; treatment of heart failure).
• Monitor Liver Function: The liver injury is usually reversible with prompt correction of ischemia, but repeated ischemic events can lead to chronic damage.

Key Considerations for Residents:

• Rapid recognition and correction of circulatory compromise can prevent irreversible liver injury.
• Consider ischemic hepatitis in any patient with cardiovascular instability and marked transaminase elevation.

3. Toxin-Induced Hepatitis

Drug-induced liver injury (DILI) and alcohol are common causes of AST and ALT elevations.

Alcoholic Hepatitis:

Chronic alcohol use can lead to steatohepatitis, where AST is typically higher than ALT, often in a ratio greater than 2:1. This pattern is thought to reflect the depletion of pyridoxal phosphate (vitamin B6) in hepatocytes, which is required for ALT synthesis.

Clinical Features:

• Symptoms: Anorexia, nausea, fever, and right upper quadrant pain. In severe cases, patients may present with jaundice, coagulopathy, and encephalopathy.
• Lab Findings: Moderate elevations in AST (usually <500 IU/L) with a ratio of AST/ALT >2:1, hyperbilirubinemia, and elevated gamma-glutamyl transferase (GGT).

Management:

• Abstinence from Alcohol: Key to halting disease progression.
• Nutritional Support: Thiamine, folate, and vitamin supplementation.
• Steroids: Considered in severe cases of alcoholic hepatitis (e.g., with a Maddrey’s discriminant function >32).

Acetaminophen Toxicity:

Acetaminophen overdose is one of the most common causes of acute liver failure. AST and ALT can rise to extremely high levels (>10,000 IU/L).

Clinical Features:

• Symptoms: Initially nonspecific (nausea, vomiting), followed by jaundice, coagulopathy, and encephalopathy in severe cases.
• Lab Findings: Marked elevations in AST and ALT. Increased INR and bilirubin indicate liver failure.

Management:

• N-acetylcysteine (NAC): Effective if given early, within 8-10 hours of ingestion.
• Supportive Care: Monitoring for signs of liver failure (e.g., coagulopathy, encephalopathy) and potential liver transplantation for fulminant cases.

Key Considerations for Residents:

• Always consider DILI in patients on multiple medications, especially those known to affect the liver (e.g., acetaminophen, statins, NSAIDs).
• Inquire about alcohol use in patients with an AST/ALT ratio >2.

Diagnostic Approach to AST/ALT Elevation

When evaluating a patient with elevated liver enzymes, a systematic approach is essential to narrow down the differential diagnosis:

1. History and Physical Examination:
   • History: Inquire about recent medication use, alcohol consumption, illicit drug use, and any recent viral illnesses.
   • Symptoms: Jaundice, fatigue, right upper quadrant pain, fever, and signs of cardiovascular instability should guide the diagnostic workup.
   • Physical Exam: Assess for hepatomegaly, signs of chronic liver disease (e.g., spider angiomas, ascites), and stigmata of alcohol abuse.
2. Laboratory Evaluation:
   • Liver Function Tests: In addition to AST and ALT, assess bilirubin, alkaline phosphatase, GGT, and prothrombin time.
   • Serologies: Hepatitis panel, autoimmune markers (ANA, SMA), and tests for Wilson’s disease or hemochromatosis as appropriate.
3. Imaging:
   • Ultrasound: To evaluate liver architecture and rule out biliary obstruction or masses.
   • CT/MRI: May be indicated if there is suspicion of malignancy or complex pathology.
4. Liver Biopsy:
   • Consider in cases of unexplained liver enzyme elevation or suspected autoimmune or drug-induced liver disease.

Conclusion

For internal medicine residents, understanding the patterns of AST and ALT elevation, coupled with a comprehensive history and targeted diagnostic workup, is crucial in the accurate diagnosis and management of liver disease. Whether dealing with viral hepatitis, ischemic injury, or toxin-induced damage, prompt identification and treatment can significantly improve patient outcomes.

By mastering these concepts, residents can ensure they provide high-quality care to patients with liver dysfunction, navigating the complexities of hepatology with confidence and skill.